Clinical trial
SARS -CoV-2 Detection in Saliva Samples: A Test Validation Protocol
NCT04517682 is registered in ClinicalTrials.gov with Ambry Genetics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SARS -CoV-2 Detection in Saliva Samples: A Test Validation Protocol
- Lead sponsor
- Ambry Genetics
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 21, 2020
- Completion date
- August 5, 2021
- Enrollment
- 67 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.